Radioligand Therapy for Prostate Cancer: The New Kid on the Block

Radioligand Therapy for Prostate Cancer: The New Kid on the Block

From The Cancer Assist Podcast by Cancer Assistance Program

May 15, 2026 · 42 min

About this episode

This episode discusses the innovative radioligand therapy for advanced prostate cancer with expert guests.

A promising new treatment is changing the landscape for advanced prostate cancer. In this episode, Dr. Bill Evans is joined by Dr. Ali Khan Lalani, Associate professor, McMaster University GU disease site team chair, Juravinski Cancer Centre, and Anne Khoorshed, Radiation Safety Officer, Hamilton Health Sciences and St. Joseph’s Healthcare Hamilton, to explore radioligand therapy (Pluvicto), an innovative targeted treatment now available in Hamilton. They break down how this “smart bomb” appr...

People in this episode

Host: Dr. Bill Evans

Guests: Dr. Ali Khan Lalani, Anne Khoorshed

Topics covered

  • radioligand therapy
  • prostate cancer
  • advanced cancer treatment
  • targeted therapy
  • healthcare innovation

Keywords

  • radioligand therapy
  • prostate cancer
  • Pluvicto
  • targeted treatment
  • healthcare

Mentioned in this episode

Organizations: McMaster University, Juravinski Cancer Centre, Hamilton Health Sciences, St. Joseph’s Healthcare Hamilton

Products: Pluvicto

More episodes of The Cancer Assist Podcast

Explore listener stats, chart rankings, contacts and more on the The Cancer Assist Podcast podcast page.